hFCRN(2)
品系全名
C57BL/6JSmo-Fcgrttm2(hFCGRT)Smoc
目录号
NM-HU-190070
品系状态
活体
基因信息
基因名
Fcgrt
品系描述
验证数据

Fig1. Validation of hFCGRT and mFCGRT expression in humanized Fcgrt mice by WB. These results showed that hFCGRT can be expressed in the liver and kidney of humanized Fcgrt homozygous and heterozygous mice,while mFCGRT can not be expressed in the humanized Fcgrt homozygous mice.

Fig2. Detection of FCRN expression in hFCRN(2) mice by WB. The spleen, large intestine and small intestine tissue lysates were collected from 12-week-old female wild-type C57BL/6 mice and 12-week-old female homozygous hFCRN(2) mice, and then analyzed by western blot with anti-FCRN antibody. FCRN was detectable in spleen, large intestine from both WT C57BL/6 and HO hFCRN(2) mice.
Abbr. HO, homozygous; WT, wild type.

Fig3. Blood concentration curves of Keytruda in C57BL/6 and hFcRn KI mice. (n=3/time point/group)

Fig4. Blood concentration curves of Cyramza(A) and Keytruda(B) in C57BL/6, hFcRn KI and Fcgrt-KO mice.(n=3/time point/group)

Fig5. In vivo PK profiles of TAA scfv-anti HSA VHH in hALB/hFCRN mice(NM-HU-200278) (female, 10-12weeks, n=3 mice/timepoint), which were generated by crossing hFCRN(NM-HU-190070) with hALB(NM-HU-200003). (In cooperation with the third party).

Fig6. Blood concentration curves of test articles in C57BL/6 and hFcRn/hALB dKI mice(NM-HU-200278), which were generated by crossing hFCRN(NM-HU-190070) with hALB(NM-HU-200003).(In cooperation with the third party)

Fig7. Pharmacokinetic analysis of IBI112 in HO hFcRn mice. (A) Body weight. (B) Pharmacokinetic analysis parameters. On Day 0, WT C57BL/6 and Hom hFcRn mice were intravenously injected via the tail vein with IBI112 (hIgG1 Fc) and the YTE-modified IBI112 antibody (5 mg/kg), respectively. Blood was drawn at the indicated times, and serum was obtained for pharmacokinetic analysis (n=3 females, 8-10 weeks old). The results showed that, although a prolonged half-life of the YTE-modified IBI112 antibody in Hom hFcRn mice compared to WT C57BL/6 mice, the difference was not statistically significant due to large within-group variation. Data are shown as mean ± SEM.
发表文献 2篇
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。
查看Cre-lox系统介绍及使用汇总
你一定听说过Cre-lox重组系统,无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点,如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统,可以在特定细胞、组织或整个生物体,甚至在特定时间点敲除或表达某个基因,实现对特定基因的时空特异性操作,这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
查看
